Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD

Human Genetics

Volumn 132, Issue 1, 2013, Pages 79-90

  Hansel, Nadia N ^a,b   Ruczinski, Ingo ^c   Rafaels, Nicholas ^a   Sin, Don D ^d   Daley, Denise ^d   Malinina, Alla ^a   Huang, Lili ^a   Sandford, Andrew ^d   Murray, Tanda ^a   Kim, Yoonhee ^e   Vergara, Candelaria ^a   Heckbert, Susan R ^f,s   Psaty, Bruce M ^f,s   Li, Guo ^f   Elliott, W Mark ^d   Aminuddin, Farzian ^d   Dupuis, Josée ^g,i   O'Connor, George T ^h,i   Doheny, Kimberly ^b   Scott, Alan F ^b   Boezen, H Marike ^j,k   Postma, Dirkje S ^j,k   Smolonska, Joanna ^j   Zanen, Pieter ^k   Mohamed Hoesein, Firdaus A ^k   De Koning, Harry J ^l   Crystal, Ronald G ^m   Tanaka, Toshiko ⁿ   Ferrucci, Luigi ⁿ   Silverman, Edwin ^o   Wan, Emily ^o   Vestbo, Jorgen ^p   Lomas, David A ^q   Connett, John ^r   Wise, Robert A ^a   Neptune, Enid R ^a   Mathias, Rasika A ^a   Paré, Peter D ^d   Beaty, Terri H ^c   Barnes, Kathleen C ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ FRAMINGHAM HEART STUDY   (United States)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁿ NATIONAL INSTITUTE ON AGING   (United States)

^o BRIGHAM AND WOMEN S HOSPITAL   (United States)

^p UNIVERSITY OF COPENHAGEN   (Denmark)

^q UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^r UNIVERSITY OF MINNESOTA   (United States)

^s CENTER FOR HEALTH STUDIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANK3 GENE; ARTICLE; CHROMOSOME 10; CHROMOSOME 14; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; HEPATOCYTE NUCLEAR FACTOR 3ALPHA GENE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SINGLE NUCLEOTIDE POLYMORPHISM; TMEM26 GENE;

ADULT; ANKYRINS; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 14; COHORT STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84872332820     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-012-1219-6     Document Type: Article

References (38)

1. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272:1497-1505
2. Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE (2005) Bronchodilator response in the lung health study over 11 years. Eur Respir J 26:45-51
3. Bakke PS, Zhu G, Gulsvik A, Kong X, Agusti AG, Calverley PM, Donner CF, Levy RD, Make BJ, Pare PD, Rennard SI, Vestbo J, Wouters EF, Anderson W, Lomas DA, Silverman EK, Pillai SG (2011) Candidate genes for COPD in two large data sets. Eur Respir J 37:255-263
4. Besnard V, Wert SE, Kaestner KH, Whitsett JA (2005) Stage-specific regulation of respiratory epithelial cell differentiation by Foxa1. Am J Physiol Lung Cell Mol Physiol 289:L750-L759
5. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM (2008) Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 178:332-338
6. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, Demeo DL, Hunninghake GM, Litonjua AA, Sparrow D, Lange C, Won S, Murphy JR, Beaty TH, Regan EA, Make BJ, Hokanson JE, Crapo JD, Kong X, Anderson WH, Tal-Singer R, Lomas DA, Bakke P, Gulsvik A, Pillai SG, Silverman EK (2010) Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42:200-202
7. Clarke DL, Clifford RL, Jindarat S, Proud D, Pang L, Belvisi M, Knox AJ (2010) TNFalpha and IFNgamma synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kappaB, and the transcriptional coactivator CREB-binding protein. J Biol Chem 285:29101-29110
8. Connett JE, Kusek JW, Bailey WC, O'Hara P, Wu M (1993) Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control Clin Trials 14:3S-19S
9. Gottlieb DJ, Wilk JB, Harmon M, Evans JC, Joost O, Levy D, O'Connor GT, Myers RH (2001) Heritability of longitudinal change in lung function. The Framingham study. Am J Respir Crit Care Med 164:1655-1659
10. Hansel NN, Gao L, Rafaels NM, Mathias RA, Neptune ER, Tankersley C, Grant AV, Connett J, Beaty TH, Wise RA, Barnes KC (2009) Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J 34:103-110
11. Hansel NN, Sidhaye V, Rafaels NM, Gao L, Gao P, Williams R, Connett JE, Beaty TH, Mathias RA, Wise RA, King LS, Barnes, KC (2010) Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease. PLoS One 5:e14226
12. He JQ, Ruan J, Connett JE, Anthonisen NR, Pare PD, Sandford AJ (2002) Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 166:323-328
13. He JQ, Connett JE, Anthonisen NR, Sandford AJ (2003) Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers. Am J Respir Cell Mol Biol 28:379-385
14. He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ (2004) Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 170:388-394
15. He JQ, Burkett K, Connett JE, Anthonisen NR, Pare PD, Sandford AJ (2006) Interferon gamma polymorphisms and their interaction with smoking are associated with lung function. Hum Genet 119:365-375
16. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645-2653
17. Hoock TC, Peters LL, Lux SE (1997) Isoforms of ankyrin-3 that lack the NH2-terminal repeats associate with mouse macrophage lysosomes. J Cell Biol 136:1059-1070
18. Kanner RE (1996) Early intervention in chronic obstructive pulmonary disease. A review of the Lung Health Study results. Med Clin North Am 80:523-547
19. Kanner RE, Connett JE, Williams DE, Buist AS (1999) Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 106:410-416
20. Khoury MJ, Beaty TH, Tockman MS, Self SG, Cohen BH (1985) Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors. Genet Epidemiol 2:155-166
21. Kizhatil K, Yoon W, Mohler PJ, Davis LH, Hoffman JA, Bennett V (2007) Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells. J Biol Chem 282:2029-2037
22. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC (2002) Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir Care 47:1184-1199
23. Minino AM (2011) Death in the United States, 2009. NCHS Data Brief, pp 1-8
24. Molfino NA (2007) Genetic predisposition to accelerated decline of lung function in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2:117-119
25. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: global Burden of Disease Study. Lancet 349:1498-1504
26. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der HP, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, Wain LV, Elliott KS, Teumer A, Luan J, Lucas G, Kuusisto J, Burton PR, Hadley D, McArdle WL, Brown M, Dominiczak A, Newhouse SJ, Samani NJ, Webster J, Zeggini E, Beckmann JS, Bergmann S, Lim N, Song K, Vollenweider P, Waeber G, Waterworth DM, Yuan X, Groop L, Orho-Melander M, Allione A, Di GA, Guarrera S, Panico S, Ricceri F, Romanazzi V, Sacerdote C, Vineis P, Barroso I, Sandhu MS, Luben RN, Crawford GJ, Jousilahti P, Perola M, Boehnke M, Bonnycastle LL, Collins FS, Jackson AU, Mohlke KL, Stringham HM, Valle TT, Willer CJ, Bergman RN, Morken MA, Doring A, Gieger C, Illig T, Meitinger T, Org E, Pfeufer A, Wichmann HE, Kathiresan S, Marrugat J, O'Donnell CJ, Schwartz SM, Siscovick DS, Subirana I, Freimer NB, Hartikainen AL, McCarthy MI, O'Reilly PF, Peltonen L, Pouta A, de Jong PE, Snieder H, van Gilst WH, Clarke R, Goel A, Hamsten A, Peden JF, Seedorf U, Syvanen AC, Tognoni G, Lakatta EG, Sanna S, Scheet P, Schlessinger D, Scuteri A, Dorr M, Ernst F, Felix SB, Homuth G, Lorbeer R, Reffelmann T, Rettig R, Volker U, Galan P, Gut IG, Hercberg S, Lathrop GM, Zelenika D, Deloukas P, Soranzo N, Williams FM, Zhai G, Salomaa V, Laakso M, Elosua R, Forouhi NG, Volzke H, Uiterwaal CS, van der Schouw YT, Numans ME, Matullo G, Navis G, Berglund G, Bingham SA, Kooner JS, Connell JM, Bandinelli S, Ferrucci L, Watkins H, Spector TD, Tuomilehto J, Altshuler D, Strachan DP, Laan M, Meneton P, Wareham NJ, Uda M, Jarvelin MR, Mooser V, Melander O, Loos RJ, Elliott P, Abecasis GR, Caulfield M, Munroe PB (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41:666-676
27. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, Ruppert A, Lodrup Carlsen KC, Roses A, Anderson W, Rennard SI, Lomas DA, Silverman EK, Goldstein DB (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 5:e1000421
28. Rennard SI, Vestbo J (2006) COPD: the dangerous underestimate of 15 %. Lancet 367:1216-1219
29. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Pare PD (2001) Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 163:469-473
30. Siedlinski M, Boezen HM, Boer JM, Smit HA, Postma DS (2009a) ABCC1 polymorphisms contribute to level and decline of lung function in two population-based cohorts. Pharmacogenet Genomics 19:675-684
31. Siedlinski M, Postma DS, Boer JM, van der SG, Schouten JP, Smit HA, Boezen HM (2009b) Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population. Respir Res 10:73
32. Song L, Wei X, Zhang B, Luo X, Liu J, Feng Y, Xiao X (2009a) Role of Foxa1 in regulation of bcl2 expression during oxidative-stress-induced apoptosis in A549 type II pneumocytes. Cell Stress Chaperones 14:417-425
33. Song L, Zhang B, Feng Y, Luo X, Wei X, Xiao X (2009b) A role for forkhead box A1 in acute lung injury. Inflammation 32:322-332
34. Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I (2006) State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 3:503-510
35. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM (2005) A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am.J Respir. Crit Care Med 172:329-333
36. van Diemen CC, Postma DS, Siedlinski M, Blokstra A, Smit HA, Boezen HM (2011) Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts. Respir Res 12:57
37. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, Macnee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365:1184-1192
38. Zeger SL, Liang KY, Albert PS (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44:1049-1060